Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
QSOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HOXB9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SULF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPRIN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR3C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEF2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAST4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLCCI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NECAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on